Actively Recruiting
Fertility Protection for Children, Adolescents, and Young Adults Undergoing Cancer Treatments or Stem Cell Transplantation
Led by University of Ulm · Updated on 2025-01-16
2000
Participants Needed
1
Research Sites
1038 weeks
Total Duration
On this page
Sponsors
U
University of Ulm
Lead Sponsor
G
German Federal Ministry of Education and Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve fertility preservation and long-term care for children, adolescents, and young adults (CAYA) who undergo cancer treatments or stem cell transplantation. These treatments can harm fertility, making it essential to provide appropriate support and follow-up care. The study focuses on understanding fertility risks, addressing patient and family needs, and enhancing clinical care practices. The program involves creating a database to collect detailed medical information from patients before, during, and after cancer therapies. It will study the prevalence and long-term effects of fertility problems, document fertility preservation methods like freezing eggs or sperm, and track treatments for late effects. Researchers will also assess patients' and families' quality of life related to fertility and their informational needs, aiming to improve care structures. Participants will be involved through regular medical evaluations, including collecting therapy-related hormonal, body composition, and laboratory data. The study will monitor fertility-related outcomes over time, focusing on predictors of fertility disorders and the impact on quality of life. The long-term goal is to establish an interdisciplinary center to support fertility preservation and enhance care for young cancer patients.
CONDITIONS
Official Title
Fertility Protection for Children, Adolescents and Young Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children, adolescents, or young adults diagnosed with cancer before the age of 21 years
- Children, adolescents, or young adults undergoing stem cell transplantation for malignant or non-malignant conditions before the age of 21 years
- Treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Sektion Pädiatrische Endokrinologie und Diabetologie
Ulm, Baden-Wurttemberg, Germany, 89075
Actively Recruiting
Research Team
C
Christian Denzer, Prof. Dr.
M
Martin Wabitsch, Prof. Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here